Nasdaq · Healthcare
rYojbaba Co., Ltd. (RYOJ)
As-reported financials and recent SEC filings for rYojbaba Co., Ltd., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$9.3M
Net income
$119,394
Net margin
1.3%
Diluted EPS
$0.01
ROE
2.0%
P/E (TTM)
—
Market cap
—
Debt / equity
0.5×
Income statement (as reported)
| Line | FY2025 | FY2025 | FY2025 |
|---|---|---|---|
| Revenue | $9.3M | $11.6M | $11.0M |
| Gross profit | $2.5M | $4.5M | $3.7M |
| Operating income | $-755,407 | $1.9M | $1.3M |
| Net income | $119,394 | $1.3M | $770,571 |
| Diluted EPS | $0.01 | $0.13 | $0.08 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
6-K2026-06-15
View on EDGAR →6-K2026-04-14
View on EDGAR →20-F/A2026-04-08
View on EDGAR →6-K2026-03-30
View on EDGAR →20-F2026-03-23
View on EDGAR →32026-03-18
View on EDGAR →32026-03-18
View on EDGAR →32026-03-18
View on EDGAR →Largest Healthcare peers
Go deeper on RYOJ
Search rYojbaba Co., Ltd.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeOr check your whole portfolio free — no account needed.
Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.